Xencor, Inc. 13D and 13G filings for INmune Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-02 4:50 pm Unchanged | 2023-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,885,533 9.600% | 0 (Unchanged) | Filing |
| 2023-02-15 5:06 pm Unchanged | 2022-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,885,533 10.500% | 0 (Unchanged) | Filing |
| 2022-02-10 12:40 pm Purchase | 2021-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,885,533 10.600% | 194,533 (+11.50%) | Filing |
| 2021-01-22 5:01 pm Purchase | 2020-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,691,000 12.500% | 36,000 (+2.18%) | Filing |
| 2020-02-14 10:49 am Purchase | 2019-12-31 | 13G | INmune Bio, Inc. INMB | Xencor Inc XNCR | 1,655,000 15.300% | 1,655,000 (New Position) | Filing |